SLAMF7:在多发性骨髓瘤中 CAR T 细胞治疗的潜在目标
Caterina Alati1,2, Martina Pitea1,2, Gaetana Porto1,2
1Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli", 89133 Reggio Calabria, Italy.
Cancers
|November 13, 2025
概括
信号淋巴细胞激活分子家族成员7 (SLAMF7) 是对抗多发性骨髓瘤 (MM) 的CAR-T细胞治疗的有希望的标. 需要工程解决方案来防止在针对SLAMF7.7时进行CAR T细胞兄弟杀戮.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 信号淋巴细胞激活分子家族成员7 (SLAMF7) 在所有疾病阶段的多发性骨髓瘤 (MM) 细胞上高度表达.
- SLAMF7在免疫细胞粘附和通信中发挥作用,影响MM的发展和进展.
- 抗SLAMF7抗体埃洛图祖马布通过激活免疫细胞对抗髓瘤细胞,并具有有限的副作用,证明了临床成功.
研究的目的:
- 探索SLAMF7作为多发性骨髓瘤 (MM) 中CAR T细胞治疗的潜在点.
- 概述SLAMF7在MM中的作用及其在CAR T细胞治疗中的潜力.
- 突出CAR T细胞兄弟杀戮的挑战以及对工程解决方案的需求.
主要方法:
- 关于SLAMF7,多发性骨髓瘤和CAR T细胞治疗的现有文献的综述.
- 对MM中SLAMF7表达模式及其在疾病进展中的作用的分析.
- 讨论SLAMF7作为治疗点的临床验证.
主要成果:
- SLAMF7是MM中验证的标,在正常组织上表现出特异性和有限的表达.
- SLAMF7 CAR T细胞疗法为BCMA-CAR疗法提供了一个潜在的替代方案.
- 卡尔T细胞兄弟杀伤是一个重大挑战,需要为SLAMF7向疗法提供工程解决方案.
结论:
- SLAMF7是多发性骨髓瘤中CAR T细胞治疗的可行和临床验证的标.
- 需要进一步的研究来应对工程挑战,特别是CAR T细胞兄弟杀伤.
- 针对SLAMF7的CAR T细胞疗法对未来的MM治疗策略具有前景.
更多相关视频
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.7K
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.8K
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
